University of Miami Researchers Receive Approval to Begin Stem Cell Trial Using BioCardia Catheter to Treat Heart Failure
May 01, 2008
May 01, 2008
MIAMI, May 1 -- University of Miami of Miller School of Medicine issued the following news release:
Stem cell researchers at the University of Miami Miller School of Medicine continue to blaze scientific trails with another first. They have received approval from the Food and Drug Administration for a study using a Helical Infusion catheter system to inject stem cells into the heart. BioCardia, a California-based biotechnology company, developed the minimally invasive percutaneous . . .
Stem cell researchers at the University of Miami Miller School of Medicine continue to blaze scientific trails with another first. They have received approval from the Food and Drug Administration for a study using a Helical Infusion catheter system to inject stem cells into the heart. BioCardia, a California-based biotechnology company, developed the minimally invasive percutaneous . . .